Sonnet BioTherapeutics Holdings, Inc. (SONN) Stock price, Description, News & Info

#Thinksabio latest news

Sonnet BioTherapeutics Expands Clinical Evaluation of SON-1010 Dose Escalation with Atezolizumab in Ovarian Cancer